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Epidemiology of paroxysmal atrial fibrillation
J. Goudevenos, J. Vakalis, V. Lathridou, E. Pappa, A. Papathanasiou,
L  Michalis, D. Sideris. Department of Cardiology, University Hospital of 
loannina, 45110 ioannina, Greece
Background. Despite its high prevalence little is known regarding the epidemiol­
ogy of paroxysmal atrial fibrillation (PAF). The aim of the study was to determine 
the incidence and other epidemiological features of PAF.
Methods«Over a 4/year period we conducted a prospective, population-based 
survey of cases of PAF in a closed population (160,000 inhabitants). Sources 
for identification of potential cases were the two general district hospitals which 
serve the studied population. Only patients who suffered at least one episode 
of PAF ( <7 days duration, with abrupt well defined onset of symptoms) out 
of hospital were included. Patients with PAF complicating acute myocardial 
infarction, acute pericarditis or acute infection were excluded.
Results. We identified 391 patients (236 men-155 women) with PAF. The over­
all annual incidence was 9 cases per 10,000 inhabitants (male: 12/10,000/year 
vs female: 6/10,000/year). PAF occurred in lower age in men (mean age 57 
±  16 years) than in women (mean age 64 ±  16 years) [p < 0.001]. The inci­
dence rose with age with the highest rates of incidence among people 60-69 
years (28/10,000 for men, 18/10,000 for women), in the elderly (> 70 years) 
the incidence was similar for both sexes (16/10,000 for men, 15/10,000 for 
women). 122 (31%) patients had more than one episode (23% before and 8% 
after enrollment). In 37% of cases no cardiovascular risk factor was identified. 
This was more common for the population < 70 years (45%) compared with 
the elderly (12%) [p < 0.0005]. Hypertension was the most common risk factor 
occurring in 21 % of the men and in 39% of the women. Other risk factors were 
valve disease (14%), coronary artery disease (12%), diabetes (10%), hyperthy­
roidism (5%), lung disease (3%), sick sinus and pre-excitation syndrome (2%). 
23% reported 2 or more risk factors. Heavy alcohol consumption, insomnia 
and heavy exertion were preceded in 17% of the cases. In 8% of patients the 
arrhythmia was self-terminated and in 12% DC shock was required because of 
drug therapy failure.
Conclusions; PAF is a common arrhythmia that rises with age. Occurs more 
frequently and in lower age in men than in women. Hypertension is the most 
common among the risk factors. Absence of cardiovascular risk factor is more 
usual in the population < 70 years than the elderly.
Natural history of acute atrial fibrillation
Björn Hornestam, Peter Held. Dept of Medicine, Östra University Hospital, 
Göteborg, Sweden
Acute atrial fibrillation (AF) is a common arrythmia with a considerable rate of 
complications. The natural course during the acute phase is not weil described. 
In the recent DAAF trial 110 female and 129 male patients, with a mean age 
of 66.2 years (range 21-89), with acute AF within 7 days of onset were blindly 
allocated to treatment with i.v digoxin or placebo, After 16 hours, a similar 
number of patients in each treatment group had converted to sinus rythm (SR). 
We have therefore used the total patient material to describe the natural course. 
A Cox regression model was developed, utilizing clinical data at baseline, to 
define factors predictive of conversion to SR.
The duration of AF before treatment was 21.7 + -30.4 hours (range 1.5-175 
h) and the heart rate at inclusion 122.0 + -23.0 bpm (range 62-180).
2 h 6 h 12 U 16 h
Sinus rhythm, n =  239: % 18 33 44 49
Heart rate comp, to baseline
(placebo only), n = 122: bpm -4.4 -10.1 -9.6 -3.9
Cox regression model; predictors of conversion to SR
p-value p-value
Age: 0.14 History of heart failure 0.21
Female sex: 0.06 Heart rate > 120 0.70
Duration of AF: 0.0008 Rales at inclusion 0.17
History of AF: 0.21 Digoxin treatment 0.28
In conclusion; the spontaneous rate of conversion to sinus rhythm is nearly 
50% within 12 hours, with the highest rate during the first hours. The heart rate 
remains high in patients still in AF during 16 hours of observation.
A short duration of AF was the most predictive factor, and female sex is 
associated with a positive trend, for conversion to sinus rhythm. Heart failure, 
high heart rate at inclusion and earlier AF were associated with lesser chance 
of conversion, but this effect did not reach statistical significance.
Chronic atrial fibrillation: s u c c e s s  rate of serial 
cardioversion therapy and lo n g -te rm  safety and 
efficacy of oral anticoagulation
I.e. Van Gelder, H.J.G.M. Crijns, R.G. Tieleman, J. BrOgemann, P.J. De Kam, 
A.T.M. Gosselink, F.W.A. Verheugt1, K.L Lie. Thoraxcenter, University 
Hospital Groningen; 1 University Hospital Nijmegen, The Netherlands
The purpose of this study was to determine th e  long-term success rate of the 
serial electrical cardioversion (ECV) approach in  patients with chronic atrial 
fibrillation (AF) and to assess the efficacy and sa fe ty  of oral anticoagulation in 
these patients.
Methods: Patients with chronic (>24 hours) A F  received > 4 weeks anti­
coagulant therapy (OAC) prior to ECV. No prophylactic  antiarrhythmic agent 
was given after the first ECV. Relapses were managed by repeated EC Vs 
whereafter serially antiarrhythmic drugs were instituted. OAC was withdrawn 
after 4 weeks sinus rhythm.
Results: 236 patients were followed for 3.7 =b 1 .6  years. Mean age was 63 ±  
12 years. Underlying disease was coronary a rte ry  disease in 28%, rheumatic 
disease in 17%, non rheumatic valvular disease in 16%, hypertension in 17% 
and 22% had “lone” AF. Median duration of A F  w as 9 months, left atrial size 
was 46 ±  8 mm. The actuarial cumulative percentages of patients maintaining 
sinus rhythm after serial ECV treatment was 4 2 %  and 27% after 1 and 4 years, 
respectively. Multivariate analysis showed that factors which were associated 
with failure of this approach included: arrhythmia duration > 36 months (risk 
ratio 5.0, p = 0.0001), poor exercise tolerance (functional class III, risk ratio 1.8, 
p = 0.001), and age > 56 years (risk ratio 1.5, p  =  0.038). The anticoagulation 
level of INR 2.4-4.8 was associated with an "incidence of thromboembolism 
and bleeding complications of 0.2% and 1.5%, respectively.
In conclusion, this study shows that many pa tien ts  with AF fail to respond 
to the serial ECV strategy. However, this approach postpones the continuous 
presence of AF which decreases the exposure tim e  to the deleterious events 
related to AF. In addition, thromboembolic events w ere infrequent in the patients 
who were subject to this regimen.
Effects of intra-venously administered digoxin in acute 
atrial fibrillation, compared to  placebo
B. Hornestam1, P. Held1, T. Carlsson2, L. F a lk 3 , B. Karlsson 4,
T. Lundstrom5, M. Pettersson6, for the DAAF S tu d y  Group.1 Department of 
Medicine, Ostra University Hospital, Goteborg; 2 Department o f Medicine, 
Varberg Hospital; 3 Department of Medicine, M o fn d a l Hospital; 4 Department 
of Medicine, Uddevalla Hospital; 5 Department o f Medicine, Skovde Hospital;
6 Department of Medicine, Lidkoping Hospital, S w eden
Acute atrial fibrillation (AF) is a common a ry thm ia . Although no controlled 
clinical trial investigating the effects of acute intravenous (i.v) treatment with 
digitalis has been reported, this treatment is w id e ly  used to control heart rate 
and to regain sinus rythm.
In a randomized, doubleblind, multicenter tr ia l we compared the effects of 
i.v administered digoxin with placebo in 239 patients (110 female/129 male, 
mean age 66.2, range 21-89 years) with atrial fibrillation of maximally 7 days 
duration (mean duration 22.0 h, range 1.5-174.5 h). 129 patients had their first 
episode of AF, 110 had recurrent AF. Digoxin w a s  given i.v at times 0, 2 and 6 
hours after inclusion, in the dose of 0.5 mg (m e a n  0.46 mg, 0.31 mg and 0.32 
mg). The primary end-point was conversion to  sinus rythm. Effects on heart 
rate were one secondary end-point. The dura tion  o f the study was 16 h, from 
inclusion. The groups were demographically w e ll matched. 117 patients were 
randomized to digoxin, and 122 to placebo.
There were no significant difference in ra te  o f conversion to sinusrythm 
between the groups. Conversion to sinus rythm occurred earlier in the digitalis 
treated group compared to placebo, but the d iffe rence  was not quite statistically 
significant. The heart rate at 16 h was significantly tower in the digitalis treated 
group, in patients still remaining in AF,
Duration of AF HR at 
baseline
HR 16 h in AF Sinusrythm
n/total
Time to SR
Digitalis
Placebo
p-valuB
20.7 ±  29.9h
22.7 ±31 .Oh 
n.s
120 ±23 
123 ±23  
n.s
91 ± 2 0  
116±25  
p < 0.0001
60/117
56/120
n.s
4.7 ±  4.2h
5.8 ±  4.9h 
p «  0.18
5 digitalis treated patients experienced s ign ifica n t bradycardia, but none 
needed treatment other than observation.
In conclusion intravenously administered d ig o x in  results In a statistically non­
significant^ earlier conversion to sinusrythm a n d  a significant decrease in heart 
rate in patients stiil in atrial fibrillation, compared to  placebo. Digitalis does not 
differ from placebo in the total conversion to  s in u s  rythm during 16 hours of 
treatment and observation.
